Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss...
Source: Tufts Center for the Study of Drug Development
- Featured Article
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain...
Source: Applied Clinical Trials
- Featured Article
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain...
Source: Applied Clinical Trials
- Press Release
The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category....
- Featured Article
Clinical trial complexity is now the norm: more endpoints, more procedures, narrower eligibility criteria, and more...
Source: pharmaphorum
- Press Release
Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...
- Featured Article
New peer-reviewed research puts hard numbers to the financial value of RBQM, showing ROI multiples up...
Source: The Association of Clinical Research Professionals
- Featured Article
Clinical research associates are evolving from compliance-focused manual monitors to data-enabled strategic site partners, but organizations...
Source: Applied Clinical Trials
- Featured Article
Clinical trials have undergone a period of immense change. Use of real-world data (RWD) is increasing....
Source: PharmaLive
- Press Release
Wayne, PA – July 27, 2026 – CluePoints, provider of leading statistical and AI-driven software solutions,...
- Featured Article
How risk-based quality management (RBQM) can harness the power of AI and advanced analytics to transform...
Source: Journal for Clinical Studies
- Press Release
New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA: CluePoints,...
- Press Release
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the...
- Press Release
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Press Release
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational...
- Press Release
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
- Press Release
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is now open....
- Press Release
Are you struggling with how to assess the true value of improving data quality and integrity...
- Featured Article
The theme for this year’s International Women’s Day (IWD) on 8th March was ‘Give to Gain’....
Source: Pharmaphorum
- Featured Article
Quality tolerance limits (QTLs) are trial-level thresholds on critical-to-quality (CtQ) factors—key measures where sustained deviation could...
Source: Applied Clinical Trials
- Featured Article
Risk-based quality management (RBQM) is becoming central to clinical trial oversight, with ICH E6(R3) emphasising proportional,...
Source: Discover Pharma
- Featured Article
Analysis of more than 880 clinical trials shows that while statistical data monitoring and key risk...
Source: Applied Clinical Trials
- Featured Article
As AI finds solid footing in pharma R&D, the technology is slated to yield significant rewards....
Source: PharmaVoice
- Featured Article
To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News...
Source: Clinical Research News
- Featured Article
Dan Beaudry, market owner for risk-based quality management (RBQM) at CluePoints, explains how regulatory shifts and...
Source: Discover Pharma
- Featured Article
Returning to the series is CluePoints, with Sophie Henderson, senior strategic consultant, sharing her hopes and...
Source: Discover Pharma
- Featured Article
Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted...
Source: International Pharmaceutical Industry
- Featured Article
Sophie Henderson, Senior Strategic Consultant at CluePoints, said: “This year we have seen risk-based quality management...
Source: Discover Pharma
- Featured Article
As clinical trials become more complex, leading sponsors are shifting the focus of their clinical research...
Source: The Association of Clinical Research Professionals
- Featured Article
Source: Applied Clinical Trials